Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide drug sold as Mounjaro (type 2 diabetes) and Zepbound (weight management).
What is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide drug sold as Mounjaro (type 2 diabetes) and Zepbound (weight management). It is a 39-amino-acid modified peptide given by injection under clinician supervision. Strong trial data for glucose control and weight loss—but not comparable to collagen powder, cosmetic serums, or research peptides sold online.
Where you will see Tirzepatide
On product labels, look for the INCI name in the full ingredient list—not just front-of-pack nicknames. Concentration, formula pH, and what else is in the bottle all change how a peptide behaves on skin or hair.
How tirzepatide differs from semaglutide
Both are incretin-based weight and diabetes medicines, but tirzepatide activates both GIP and GLP-1 receptors while semaglutide is primarily GLP-1. Dosing, side effects, and insurance coverage differ—only a prescriber should choose between them.
Related peptides in our directory
Common questions
What does Tirzepatide mean?
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide drug sold as Mounjaro (type 2 diabetes) and Zepbound (weight management). It is a 39-amino-acid modified peptide given by injection under clinician supervision. Strong trial data for glucose control and weight loss—but not comparable to collagen powder, cosmetic serums, or research peptides sold online.
Is Tirzepatide an INCI ingredient name?
Sometimes. Brands use nicknames on the front label and INCI names on the back. Search our directory with either form to find the matching peptide page.